Bio decontamination is largely defined as the process of neutralization as well as the removal of infectious microorganisms, chemical agents and radioactive materials. This can be attained by biology or chemicals based methods as well as by physical means.
What the Biological Decontamination Market Looks Like?
The bio decontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1%
Pharmaceuticals and Medical Devices Companies:
On the basis of end user, the biodecontamination market is segmented into pharmaceutical & medical device manufacturing companies, hospitals & healthcare facilities, and life sciences & biotechnology research organizations. In 2018, the pharmaceutical & medical device manufacturing companies segment accounted for the largest market share and highest growth rate, owing to the growing adoption of biodecontamination products & services by pharmaceutical and medical device manufacturing industries to adhere to stringent regulations.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777
Key Factors Driving Growth in Bio Decontamination Industry:
1. Rising Incidence of Hospital-Acquired Infections
2. Increasing Number of Surgical Procedures
3. Increasing Outsourcing of Bio decontamination Services
4. Growth in the Pharmaceutical and Biotechnology Industries
5. Presence of Stringent Regulations
Emerging economies are expected to provide a wide range of growth opportunities for players in the market.
The study objectives are to present Bio Decontamination Market development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Read more: https://www.marketsandmarkets.com/Market-Reports/bio-decontamination-market-104696777.html
Key Players in Bio Decontamination Market:
The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc. (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy).
Rapid advances in technology have demonstrated the capability of terahertz spectroscopy in various healthcare applications.
The focus on using terahertz spectroscopy in biomedical applications has increased rapidly, and several studies are being conducted to investigate its potential applications in pharmaceutical quality control, protein characterization, and cancer detection.
T-rays are non-invasive and non-ionizing and thus can be focused harmlessly on the body to capture signs of cancer.
This is key factor increasing demand of molecular spectroscopy market.
What the Industry Looks Like?
The global molecular spectroscopy market is expected to reach USD 6.85 billion by 2022 from USD 4.98 billion in 2017, at a CAGR of 6.6%.
According to the new market research report “Single-Use Assemblies Market by Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly), Application (Filtration, Storage), Solution (Standard, Customized), End User (Pharmaceutical Companies, CMOs and CROs) – Global Forecast to 2024” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The single-use assemblies market is projected to reach USD 1,825 million in 2024 from USD 805 million in 2019, at CAGR of 16.5% during the forecast periodGrowth Boosting Factors:– Rapid Implementation and Low Risk of CROs s-Contamination– Increasing Biopharmaceutical R– Emerging CountriesBrowse 102 Market Data Tables and 33 Figures spread through 148 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549Leading Key Players in the Worldwide Industry:The major companies in the single-use assemblies market include Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher (US), Merck Millipore (Germany)), and GE Healthcare (US).Sartorius Stedim Biotech (France) is the most significant player in the global market.
The company has an expansive range of single-use assemblies products.
The growth of revenue strongly backed up by demand from the Americas and APAC countries and efforts of the company to meet the differentiated needs of consumers from emerging Asian markets.
The company launched two single-use filter assemblies products in the past three years, including such as Sartocon Self-contained Filter Loop Assembly and Sartocon Slice Self-contained Bag Loop Assembly.
The company also focuses on inorganic growth strategies such as partnership, collaboration, and acquisitions to strengthen its position in the market.Geographical Regions Mapped in Report:The single-use assemblies market is divided into four major regions-Europe, North America, Asia Pacific, and the Rest of the World (RoW).
In 2018, North America accounted for the largest share of the global market, closely followed by Europe.
According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.
However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market"148 - Tables186 - Pages36 - FiguresOrder a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.
Each segment has different market players and market leaders.
For instance, the prediabetes market was led by Omada in 2015.
Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.
Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.
